Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Deschatelets Pascal
Relationship:   Chief Scientific Officer
City:   Crestwood
State:   KY
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   1,140,483    

Indirect Shares

   0      
Direct Value   $44,763,958    

Indirect Value

   $0      
Total Shares   1,140,483      
Total Value   $44,763,958      


Apellis Pharmaceuticals Inc $44,763,958 Apellis Pharmaceuticals Inc $44,763,958
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    5    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    5    
   
     Gain/Loss Ratio :
   0.0   
   -5.0   
     Percentage Gain/Loss :
     0.0%
 -165.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Apellis Pharmaceuticals Inc APLS Chief Scientific Officer 2024-05-20 1,140,483 2018-05-07 0    Premium*  
* Premium Members only  

Records found :    80         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-04-29 4 OE $2.67 $10,680 D/D 4,000 895,775 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-06-17 4 OE $2.67 $88,123 D/D 33,005 931,280 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-07-08 4 OE $2.67 $49,395 D/D 18,500 949,780 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-08-08 4 OE $2.67 $49,395 D/D 18,500 956,280 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-09-08 4 OE $2.67 $49,395 D/D 18,500 962,780 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-10-10 4 OE $2.67 $49,395 D/D 18,500 969,280 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       –      –    2022-11-08 4 OE $2.67 $49,395 D/D 18,500 975,780 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-12-08 4 OE $2.67 $49,395 D/D 18,500 982,280 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2022-12-29 4 OE $3.67 $25,690 D/D 7,000 977,280 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-01-09 4 OE $2.67 $49,395 D/D 18,500 995,780 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-02-08 4 OE $2.67 $49,395 D/D 18,500 1,018,756 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-03-08 4 OE $2.67 $49,395 D/D 18,500 1,032,813 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-04-10 4 OE $2.67 $49,395 D/D 18,500 1,039,313 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-05-08 4 OE $2.67 $49,395 D/D 18,500 1,045,813 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-06-08 4 OE $2.67 $49,395 D/D 18,500 1,052,313 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-07-10 4 OE $2.67 $49,395 D/D 18,500 1,058,813 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-08-08 4 OE $2.67 $49,395 D/D 18,500 1,065,313 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-09-08 4 OE $2.67 $49,395 D/D 18,500 1,071,813 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-10-09 4 OE $2.67 $49,395 D/D 18,500 1,078,313 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-11-08 4 OE $2.67 $46,709 D/D 17,494 1,083,807 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2023-11-14 4 OE $3.76 $169,200 D/D 45,000 1,116,807 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2024-03-08 4 OE $3.67 $253,623 D/D 69,107 1,185,090 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2024-04-08 4 OE $3.76 $259,842 D/D 69,107 1,185,090 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2024-05-08 4 OE $4.31 $340,089 D/D 78,907 1,194,890 0 -
APLS Apellis Pharmaceuticals I... Chief Scientific Officer   •       •      –    2024-05-20 4 OE $3.76 $92,120 D/D 24,500 1,140,483 0 -
  80  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us